Got a new idea?   |   PMR Publications   |   PMR Consulting   |   PMR Research   |   PMR Online Access
 
 

Innovative drugs not yet as appreciated as the still booming generics in Central and Eastern Europe

The generics market in Central and Eastern Europe was worth almost €12bn in 2006, representing more than 50% of the monetary value of the pharmaceutical market in the region. By way of comparison, the share of generics as a proportion of the total EU pharmaceutical market is around 40%. For innovative companies Central and Eastern Europe is a comparatively difficult theatre of operations because of the relatively small amount of per capita spending on drugs and the pro-generic policies of the majority of governments in the region.

To open the FULL free article/document, please sign up.

*required

*Email:
To make sure you receive the requested information, add info@pmrcorporate.com to your company trusted emails. Contact your IT department for details.
*Your company core business:
Help us better answer your needs.
Why do you sign up?
Please specify:

Privacy Policy


 
People who downloaded this free article, have read also:
 
About us         Contact us         Privacy Policy
Copyright © 2012 PMR. All rights reserved.

PMR is a British-American company providing market information, advice and services to international businesses interested in Central and Eastern Europe as well as other emerging markets. PMR key areas of operation include business publications (through PMR Publications), consultancy (through PMR Consulting) and market research (through PMR Research). Being present on the market since 1995, employing highly skilled staff, offering high international standards in projects and publications, providing one of most frequently visited and top-ranked websites, PMR is one of the largest companies of its type in the region.